Cardiomyopathy Trial, Recruiting NCT06954103 Sponsor: Chensheng Pan Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06954103
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were admitted to hospital within 48 hours of their stroke symptoms starting, where a CT or MRI scan has confirmed they had a stroke (either a blocked blood vessel or a bleed in the brain)
  • People whose stroke has been rated as moderate to severe, based on a standard medical scoring system that measures stroke severity (a score of 5 or higher on a scale called the NIHSS)

Who may not be able to join:

  • People who have had a previous brain injury in a specific area of the brain, such as a prior stroke, brain surgery, or a traumatic brain injury
  • People whose brain problems are caused by a condition other than stroke, such as a brain tumour, epilepsy, or Parkinson's disease
  • People whose diagnosis is a transient ischemic attack (sometimes called a "mini-stroke") or a specific type of brain bleed called a subarachnoid haemorrhage
  • People with a history of heart conditions, including coronary heart disease, heart failure, serious irregular heartbeat, heart defects present from birth, previous heart surgery, heart valve problems, or unexplained significant heart symptoms
  • People with certain ongoing health conditions, including severe kidney disease, autoimmune disorders, or serious infections
  • People with a history of dementia, depression, or other mental health conditions
  • People who are unlikely to be able to attend follow-up appointments or cooperate with the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zhou Zhu, MD, PhD, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech

Phone: +8618202738845

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chensheng Pan
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

blood high-sensitivity cardiac troponin level; left ventricular ejection fraction; blood N-terminal pro-brain natriuretic peptide (NT-proBNP) level; functional outcome; death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov